Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary
hypertension, resulting from fibrotic transformation of pulmonary artery clots causing chronic …

Chronic thromboembolic pulmonary hypertension (CTEPH), a rare consequence of an acute
pulmonary embolism, is a disease that is underdiagnosed, and surgical pulmonary …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background—Chronic thromboembolic pulmonary hypertension results from incomplete
resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but …

Background—Chronic thromboembolic pulmonary hypertension, a rare complication of
acute pulmonary embolism, is characterized by fibrothrombotic obstructions of large …

Background Pulmonary hypertension (PH) is a severe, progressive disease. Although 5 PH
subgroups are recognized, reports on survival have focused mainly on pulmonary arterial …

Limited numbers of operated patients with chronic thromboembolic pulmonary hypertension
(CTEPH) are refractory to pulmonary endarterectomy (PEA) and experience persistent …

Epidemiological data for chronic thromboembolic pulmonary hypertension (CTEPH) are
limited and there are conflicting reports regarding its pathogenesis. A literature review was …

Chronic thromboembolic disease is characterised by persistent pulmonary thromboembolic
occlusions without pulmonary hypertension. Early surgical treatment with pulmonary …

Pulmonary endarterectomy (PEA) is the treatment of choice to relieve pulmonary artery
obstruction in patients with chronic thromboembolic pulmonary hypertension (CTEPH). It is a …